The joint venture will manufacture and sale an algae-based product intended to provide an alternative for other sources of Omega-3 fatty acids for the production of animal feed. Both Evonik and DSM are specialty chemical companies active -amongst others- in animal nutrition.
The Commission concluded that the proposed transaction would raise no competition concerns because the expected activities and turnover of the joint venture in the EEA are limited.
![](https://www.pig333.com/3tres3_common/dist_nou/css/images/imb5.png)
The transaction was examined under the simplified merger review procedure.
Friday October 30, 2017/ EC/ European Union.
http://europa.eu/rapid